Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Chroma and Spectri Phase 3 Randomized Clinical Trials

Author(s):
Holz, F.G.; Sadda, S.R.; Busbee, B.; Chew, E.Y.; Mitchell, P.; Tufail, A.; Brittain, C.; Ferrara, D.; Gray, S.; Honigberg, L.; Martin, J.; Tong, B.; Ehrlich, J.S.; Bressler, N.M.; Chroma Spectri Study Investigators
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-06-30
Language
English
Is part of
JAMA Ophthalmology (2018), Vol. 136, no. 6, p. 666-677
hdl
1887/79681
doi
10.1001/jamaophthalmol.2018.1544